Literature DB >> 8095087

Neuroleptic malignant syndrome and malignant hyperthermia. Important issues for the medical consultant.

T D Heiman-Patterson1.   

Abstract

Neuroleptic malignant syndrome and malignant hyperthermia share two cardinal clinical features: hypothermia and rigidity. Both syndromes can result in rhabdomyolysis and have high mortality rates if left untreated. This article reviews each syndrome and its pathogenesis and treatment.

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8095087     DOI： 10.1016/s0025-7125(16)30265-6

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  9 in total

Review 1.  Use of phenothiazines as sedatives in children: what are the risks?

Authors:  K S Dyer; A D Woolf
Journal:  Drug Saf       Date:  1999-08       Impact factor: 5.606

2.  Muscle changes in the neuroleptic malignant syndrome.

Authors:  W M Behan; M Madigan; B J Clark; J Goldberg; D R McLellan
Journal:  J Clin Pathol       Date:  2000-03       Impact factor: 3.411

3.  Risk factors in neuroleptic malignant syndrome.

Authors:  Vinay Gupta; Rakesh Magon; B P Mishra; G B S Sidhu; Ranjiv Mahajan
Journal:  Indian J Psychiatry       Date:  2003-01       Impact factor: 1.759

Review 4.  Neuroleptic malignant syndrome.

Authors:  P F Buckley; M Hutchinson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-03       Impact factor: 10.154

Review 5.  [Rhabdomyolysis and myoglobinuria].

Authors:  A Lindner; S Zierz
Journal:  Nervenarzt       Date:  2003-05-14       Impact factor: 1.214

Review 6.  The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity.

Authors:  M V Balzan
Journal:  Postgrad Med J       Date:  1998-02       Impact factor: 2.401

7.  Atypical Neuroleptic Malignant Syndrome Associated with Use of Clozapine.

Authors:  Quevedo-Florez Leonardo; Granada-Romero Juliana; Camargo-Arenas Juan Fernando
Journal:  Case Rep Emerg Med       Date:  2017-02-20

8.  A case of neuroleptic malignant syndrome induced by perospirone.

Authors:  Jing Chen; Shengli Zhi
Journal:  Shanghai Arch Psychiatry       Date:  2013-12

9.  Treatment with Botulinum Toxin for Refractory Fever Caused by Severe Spasticity: A Case Series.

Authors:  Jacobo Lester; Gerardo Esteban Alvarez-Resendiz; Enrique Klériga; Fernando Videgaray; Gerardo Zambito
Journal:  Neurol Ther       Date:  2018-01-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.